Scientists

Welcome to the new scientist and researcher reference section. Your one-stop shop for the essential resources you need to advance your career.

AACR-SNMMI Joint Conference on State-of-the-Art Molecular Imaging in Cancer Biology and Therapy.

Make plans to attend the AACR-SNMMI Joint Conference on State-of-the-Art Molecular Imaging in Cancer Biology and Therapy, taking place February 14-17, 2018 in San Diego, CA.

The collaborative meeting program will allow you to connect directly with the profession's foremost experts on the latest topics in Molecular Imaging in Cancer Biology and Therapy, including:

  • Emerging Advances in Imaging Technologies
  • Novel Ligands and Target Identification
  • Imaging Cancer Immunotherapy I: Cell-Based Therapies
  • Imaging Cancer Immunotherapy II: Checkpoint Blockade, Resistance, and Targeted Therapies
  • Early Detection of Cancer: Liquid Biopsies and Imaging
  • Pathways for Clinical Translation: Novel Agents and Strategies
  • Modeling Cancer: In Silico, In Vitro, In Vivo
  • Optics in the Oncology Surgical Suite
  • Super-resolution imaging of cancer biology and metastasis
  • Imaging Cancer Metabolism

View the educational program | Register online

Advance registration deadline: December 18, 2017

Coding and Reimbursement

The most up-to-date and comprehensive source for nuclear medicine coding and reimbursement information on the web. Please note that ALL information and materials within the SNMMI Coding Corner are direct products of the SNMMI Coding and Reimbursement Working Group.

For Hospitals (APCs, IPPS) Find general coding and reimbursement information for hospitals.

For Private Practices (RBRVS) Find general coding and reimbursement information for professionals in private practices.

Coding and Reimbursement Q&A This easy to use feature contains over 100 questions and answers related to topics such as cardiac, endocrine, neurology, nuclear medicine-related drugs, oncology, PET, PET/CT, radiopharmaceuticals, and more!

Dose Optimization

In nuclear medicine and molecular imaging, small amounts of radioactive agents are administered to the patient to allow the physician to examine molecular processes within the body. These procedures are highly effective, safe and painless diagnostic tools that present physicians with a detailed view of what’s going on inside an individual’s body at the cellular level. For more than 60 years, these studies have been used to evaluate practically all systems within the body, including the heart and brain, as well as to image many types of cancer.

SNMMI has a large body of knowledge in dose optimization that is continually growing and developing. The dose optimization website presents a wide variety of resources, including SNMMI journal articles, educational offerings, media-related information, links to useful websites and more.

 

Guidelines

The practice guidelines help to identify those elements of the procedure that are most important in obtaining a high-quality examination, while simultaneously controlling costs. Use of standardized procedures will increase the applicability of clinical research among multiple institutions, in turn, increasing the value of research studies, particularly in the field of technology assessment. In the interest of creating strong, comprehensive documents, some guidelines were formally adopted by SNMMI in collaboration with other professional organizations.

View Guidelines.

Focusing on the Future of Molecular Imaging

SNMMI's Center for Molecular Imaging Innovation and Translation is an organizational component within the SNMMI that is dedicated to all aspects of molecular imaging in the detection and management of disease. The center is currently facilitating initiatives to bring molecular imaging discoveries from the lab to the patient and to advance "personalized" medicine.

Access resources.

The Clinical Trials Network’s mission is to advance the use of molecular imaging radiopharmaceuticals in clinical trials through standardization of chemistry and imaging methodology. This includes using imaging radiopharmaceuticals during the course of drug development, as well as bringing new agents to regulatory approval. Click here to learn more about the CTN’s Oncology and Neurology Scanner Validation programs, ongoing efforts to harmonize reconstruction parameters in oncology clinical trials, and other services that CTN offers to help scientists advance their research.

Educational Offerings

SNMMI educational programs are designed to meet the professional development needs of scientists involved in nuclear medicine and molecular imaging endeavors. 

Visit the SNMMI Learning Center.


Additional Resources

  • December 11, 2017Nuclear Medicine Community Calls for Funding of Domestic Mo-99 Production

    SNMMI and other societies and organizations in the nuclear medicine community have sent joint letters to the U.S. Senate and House chairs and ranking members of the respective Subcommittees on Energy and Water Development of the Committees on Appropriations, voicing support for $67.4 million to secure a sufficient domestic supply of the medical isotope molybdenum-99 (Mo-99).
    (Government Relations News)

  • December 6, 2017PET Tracer Gauges Effectiveness of Promising Alzheimer’s Treatment

    In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the first large-scale longitudinal imaging study to evaluate BACE1 inhibition with micro-PET in mouse models of Alzheimer’s disease. PET imaging has been established as an excellent identifier of the amyloid plaque and tau tangles that characterize Alzheimer’s disease. Now it is proving to be an effective way to gauge treatment effectiveness.
    (Press Release)

  • December 4, 2017PET Scan Identifies Which Prostate Cancer Patients Can Benefit from Salvage Radiation Treatment

    For prostate cancer patients who have rising levels of PSA (a cancer indicator) even after radical prostatectomy, early treatment makes a difference. In a study featured in the December issue of The Journal of Nuclear Medicine, Australian researchers demonstrate that PET scans can identify which of these prostate cancer patients would benefit from salvage radiation treatment.
    (Press Release)

  • November 30, 2017ACNM/SNMMI Complimentary Webinar on Hybrid Imaging in Pediatrics

    Register now for the December 14 ACNM/SNMMI webinar Pediatrics Part II – Hybrid Imaging! This webinar is free for members and will be presented at 12 p.m. ET by Helen Nadel, MD, head of the Division of Nuclear Medicine at B.C. Children’s Hospital in Vancouver, B.C., Canada. Also, check out other webinar offerings.
    (SNMMI News)

Spotlight

Moving Theranostics from Bench to Bedside

Recognizing the growing and significant role in delivering precision medicine to patients, the 2018 SNMMI Mid-Winter and ACNM Annual Meeting will feature a dedicated track on Theranostics. You'll connect with the leading experts in clinical applications of theranostics, as well as the latest updates on new therapies that are currently in development.

View the educational program.

Featured Resources

  • SNMMI Councils/Centers Internship Program Call for Applications

  • Guidance

    Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.

  • Nuclear Medicine and Molecular Imaging Week: October 1-7, 2017

    Happy Nuclear Medicine Week! Encourage community members to take pride in their profession – recognizing their colleagues for their hard work and promoting nuclear medicine to the entire medical community as well as to the public.

  • Legislative Issues

    SNMMI monitors multiple federal legislative issues and provides resources including issue summaries, letters to Congress, and analysis. Most of this information is in the government relations news section of this web site.

  • SNMMI Books

    Learn more about books published by the Society of Nuclear Medicine and Molecular Imaging and the Technologist Section.